INDOMIM heads into the final week of September with a striking contradiction at its heart: the stock has surged 43% in a month, yet the people who know it best are selling.
The insider activity is the clearest signal this week. In just three days around September 9–11, multiple designated persons offloaded shares in a coordinated wave. Rangeneni Saikrishna Rayalu sold 60,000 shares for roughly ₹60.9 million. Sreenivasulu Suri sold 20,000 shares across two sessions for close to ₹19.7 million combined. Manoj Rajmal Kabre sold 15,000 shares for approximately ₹14.9 million. Ravi Bapatla trimmed 5,000 shares. Net across the 90-day window, insiders have sold a combined 789,288 shares worth roughly ₹749 million. These are open-market sales by designated persons — not transfers, not compensation mechanics — filed at significance scores that confirm them as real disposals. The stock was already rallying hard when these trades hit.
The ownership picture adds texture to that selling. Green Meadows Investments holds 76.3% of the company, leaving an extremely thin public float. Two institutional buyers — Kotak Mahindra Asset Management and Axis Asset Management — reported fresh positions as of July and August respectively, with Kotak holding 4.8% of shares and Axis 1.7%. Franklin Templeton also appears on the register. That institutional interest is a genuine counterweight to the insider selling, but it also means liquidity in the free float is scarce, which amplifies both the upside and the risk in a stock that has moved this fast.
The fundamental backdrop offers partial justification for the rally. ORTEX's stock score has climbed to 62 from 54 a month ago, driven by stronger quality and momentum signals. The most recent earnings print confirmed the improvement: operating margins expanded 240 basis points year-on-year to 18.2%, with order inflows from aerospace and automotive clients supporting the growth story. The ORTEX score does flag valuation as a modest drag — EV/EBIT has drifted wider versus sector medians — and EPS momentum has not yet fully confirmed the fundamental turn, suggesting the score may consolidate before extending further.
The earnings calendar adds a near-term focus point. The next results event is scheduled for November 17. The August print produced a 12.2% single-day move and a 4.6% gain over the following five sessions — the stock has a history of reacting sharply to quarterly releases in either direction. With the share price now 43% higher than a month ago and insiders having taken chips off the table, the November print carries more weight than usual as the next test of whether the margin improvement is sustainable or a one-quarter event.
The setup to watch: whether institutional buyers absorb the insider supply in a float this thin, and whether the November earnings confirm that the margin expansion at 18.2% is a trend rather than a point-in-time beat.
See the live data behind this article on ORTEX.
Open INDOMIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
